JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urban, P P
Right arrow Articles by Rolke, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urban, P P
Right arrow Articles by Rolke, R
Journal of Neurology Neurosurgery and Psychiatry 2004;75:1541-1546
© 2004 BMJ Publishing Group Ltd


PAPER

Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis

P P Urban1, R Rolke1,2

1 Department of Neurology, University of Mainz, Germany
2 Institute of Physiology and Pathophysiology, University of Mainz, Germany

Correspondence to:
Correspondence to:
Dr P D P P Urban
Department of Neurology, University of Mainz, Langenbeckstr. 1, D 55101 Mainz; urban{at}neurologie.klinik.uni-mainz.de

Background and aim: It has not been clarified if botulinum toxin (BTX) injection leads to muscle spindle dysfunction in man. This study aimed to test the hypothesis that BTX application reduces the facilitation of a magnetic evoked response (MEP).

Methods: We used the vibration induced facilitation of an MEP of the sternocleidomastoid muscle (SCM) as a surrogate marker for muscle spindle function in 20 healthy subjects and 10 patients with idiopathic rotational torticollis in whom BTX was injected unilaterally.

Results: The increase in the amplitude and area of the MEPs in the clinically not affected and untreated SCM of the patients did not differ significantly from the controls. At baseline, the vibration induced increase in the affected SCM of the patients was significantly lower than in the control group. Six weeks after BTX application, the observed facilitation decreased significantly (amplitude and area: p<0.001) when compared with baseline values. Twelve weeks after BTX application, facilitation showed an increase in the values of the amplitude (p<0.001), but not of the area when compared with the six week examination.

Conclusions: We demonstrated that the vibration induced MEP facilitation in the SCM of patients with torticollis significantly decreased six weeks after BTX application and again increased after 12 weeks in part when looking at MEP amplitude. This observation is suggestive of denervation and reinnervation of the muscle spindles after BTX injection.


Abbreviations: ANOVA, analysis of variance; BTX, botulinum toxin; MEP, motor evoked potential; SCM, sternocleidomastoid muscle; TMS, transcranial magnetic stimulation

Keywords: muscle spindle; botulinum toxin; spasmodic torticollis; dystonia; vibration







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.